Cardioprotective effect of ARB in old patients with hypertension and coronary artery disease - a multicenter trial.

Trial Profile

Cardioprotective effect of ARB in old patients with hypertension and coronary artery disease - a multicenter trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 22 Aug 2016

At a glance

  • Drugs Irbesartan (Primary) ; Candesartan cilexetil; Valsartan
  • Indications Coronary artery disease; Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2016 Status changed from active, no longer recruiting to discontinued.
    • 13 Aug 2013 Planned End Date changed from 30 Nov 2015 to 30 Nov 2016 as reported by University Hospital Medical Information Network - Japan.
    • 13 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top